- Home
- HELE vs MNPR Comparison
HELE vs MNPR Comparison
Compare HELE & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HELE
- MNPR
- Stock Information
- Founded
- HELE 1968
- MNPR 2014
- Country
- HELE United States
- MNPR United States
- Employees
- HELE N/A
- MNPR N/A
- Industry
- HELE Home Furnishings
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- HELE Consumer Discretionary
- MNPR Health Care
- Exchange
- HELE Nasdaq
- MNPR Nasdaq
- Market Cap
- HELE 474.4M
- MNPR 390.5M
- IPO Year
- HELE N/A
- MNPR 2019
- Fundamental
- Price
- HELE $19.55
- MNPR $78.47
- Analyst Decision
- HELE Hold
- MNPR Strong Buy
- Analyst Count
- HELE 3
- MNPR 12
- Target Price
- HELE $42.00
- MNPR $96.64
- AVG Volume (30 Days)
- HELE 1.1M
- MNPR 81.8K
- Earning Date
- HELE 10-09-2025
- MNPR 11-07-2025
- Dividend Yield
- HELE N/A
- MNPR N/A
- EPS Growth
- HELE N/A
- MNPR N/A
- EPS
- HELE N/A
- MNPR N/A
- Revenue
- HELE $1,820,033,000.00
- MNPR N/A
- Revenue This Year
- HELE N/A
- MNPR N/A
- Revenue Next Year
- HELE $3.14
- MNPR N/A
- P/E Ratio
- HELE N/A
- MNPR N/A
- Revenue Growth
- HELE N/A
- MNPR N/A
- 52 Week Low
- HELE $18.90
- MNPR $4.50
- 52 Week High
- HELE $75.68
- MNPR $105.00
- Technical
- Relative Strength Index (RSI)
- HELE 37.16
- MNPR 49.69
- Support Level
- HELE $18.90
- MNPR $76.12
- Resistance Level
- HELE $20.96
- MNPR $104.00
- Average True Range (ATR)
- HELE 1.15
- MNPR 8.32
- MACD
- HELE -0.45
- MNPR -3.88
- Stochastic Oscillator
- HELE 7.46
- MNPR 19.61
About HELE Helen of Troy Limited
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.